TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI)
CUSIP: 89455T109
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common stock, $0.001 par value
- Shares outstanding
- 63,703,704
- Total 13F shares
- 38,926,750
- Share change
- +3,283,257
- Total reported value
- $995,556,262
- Put/Call ratio
- 0%
- Price per share
- $25.58
- Number of holders
- 135
- Value change
- +$84,284,218
- Number of buys
- 89
- Number of sells
- 46
Quarterly Holders Quick Answers
What is CUSIP 89455T109?
CUSIP 89455T109 identifies TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 89455T109:
Top shareholders of TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
6%
|
3,850,045
|
$96,982,635 | — | 31 Mar 2023 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
5.1%
|
3,217,720
|
$81,054,367 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.1%
|
2,595,084
|
$65,370,165 | — | 31 Mar 2023 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
3.8%
|
2,442,250
|
$61,520,278 | — | 31 Mar 2023 | |
| John R. Treace |
3/4/5
|
Director |
—
class O/S missing
|
2,231,606
|
$59,159,875 | — | 09 May 2022 | |
| Thomas E. Timbie |
3/4/5
|
Director |
—
class O/S missing
|
1,513,064
|
$40,111,326 | — | 15 Mar 2023 | |
| NEXT CENTURY GROWTH INVESTORS LLC |
13F
|
Company |
2.4%
|
1,537,271
|
$38,723,856 | — | 31 Mar 2023 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
2.2%
|
1,411,217
|
$35,548,556 | — | 31 Mar 2023 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
2.1%
|
1,363,453
|
$34,345,381 | — | 31 Mar 2023 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
1.8%
|
1,120,875
|
$28,234,841 | — | 31 Mar 2023 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
1.7%
|
1,085,187
|
$27,336,000 | — | 31 Mar 2023 | |
| NORGES BANK |
13F
|
Company |
1.6%
|
1,005,992
|
$25,340,938 | — | 31 Mar 2023 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
962,927
|
$24,256,131 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
1.4%
|
874,704
|
$22,033,794 | — | 31 Mar 2023 | |
| TimesSquare Capital Management, LLC |
13F
|
Company |
1.3%
|
854,500
|
$21,525,000 | — | 31 Mar 2023 | |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
755,379
|
$19,027,997 | — | 31 Mar 2023 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.2%
|
752,190
|
$18,947,666 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
694,263
|
$17,488,493 | — | 31 Mar 2023 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
1.1%
|
669,448
|
$16,863,395 | — | 31 Mar 2023 | |
| KORNITZER CAPITAL MANAGEMENT INC /KS |
13F
|
Company |
1%
|
634,223
|
$15,976,077 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.88%
|
562,112
|
$14,159,601 | — | 31 Mar 2023 | |
| Novo Holdings A/S |
13F
|
Company |
0.85%
|
540,000
|
$13,602,600 | — | 31 Mar 2023 | |
| Joe W. Ferguson |
3/4/5
|
SVP, Research & Development |
—
mixed-class rows
|
754,325
mixed-class rows
|
$13,396,325 | — | 06 Oct 2021 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.69%
|
442,353
|
$11,142,872 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.65%
|
416,714
|
$10,497,026 | — | 31 Mar 2023 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.58%
|
366,443
|
$9,230,699 | — | 31 Mar 2023 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.55%
|
352,552
|
$8,880,785 | — | 31 Mar 2023 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.52%
|
331,229
|
$8,343,655 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.5%
|
319,961
|
$8,059,818 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.49%
|
312,751
|
$7,878,000 | — | 31 Mar 2023 | |
| Intrinsic Edge Capital Management LLC |
13F
|
Company |
0.46%
|
293,773
|
$7,400,142 | — | 31 Mar 2023 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.46%
|
292,461
|
$7,367,000 | — | 31 Mar 2023 | |
| Jaime A. Frias |
3/4/5
|
Chief Legal Officer |
—
mixed-class rows
|
337,008
mixed-class rows
|
$7,322,274 | — | 08 Mar 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.45%
|
288,973
|
$7,279,000 | — | 31 Mar 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.44%
|
282,905
|
$7,126,375 | — | 31 Mar 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.44%
|
281,203
|
$7,084,000 | — | 31 Mar 2023 | |
| PEREGRINE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.44%
|
280,178
|
$7,057,684 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.41%
|
263,238
|
$6,630,965 | — | 31 Mar 2023 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
0.37%
|
234,765
|
$5,913,730 | — | 31 Mar 2023 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.29%
|
184,017
|
$4,635,388 | — | 31 Mar 2023 | |
| Calamos Advisors LLC |
13F
|
Company |
0.28%
|
179,642
|
$4,525,182 | — | 31 Mar 2023 | |
| Divisadero Street Capital Management, LP |
13F
|
Company |
0.27%
|
175,000
|
$4,408,250 | — | 31 Mar 2023 | |
| OBERWEIS ASSET MANAGEMENT INC/ |
13F
|
Company |
0.24%
|
154,300
|
$3,886,817 | — | 31 Mar 2023 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.23%
|
145,559
|
$3,666,631 | — | 31 Mar 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.22%
|
139,064
|
$3,503,022 | — | 31 Mar 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.22%
|
138,604
|
$3,491,435 | — | 31 Mar 2023 | |
| Industrial Alliance Investment Management Inc. |
13F
|
Company |
0.21%
|
136,550
|
$3,440,000 | — | 31 Mar 2023 | |
| CASTLEARK MANAGEMENT LLC |
13F
|
Company |
0.2%
|
129,250
|
$3,255,808 | — | 31 Mar 2023 | |
| FORMULA GROWTH LTD |
13F
|
Company |
0.2%
|
124,900
|
$3,146,231 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.19%
|
123,701
|
$3,116,029 | — | 31 Mar 2023 |
Institutional Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) as of Q2 2023
As of 30 Jun 2023,
TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) was held by
135 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,926,750 shares.
The largest 10 holders included
VANGUARD GROUP INC, ALLIANCEBERNSTEIN L.P., BlackRock Inc., PERCEPTIVE ADVISORS LLC, NEXT CENTURY GROWTH INVESTORS LLC, Driehaus Capital Management LLC, Point72 Asset Management, L.P., CIBC Private Wealth Group, LLC, EMERALD ADVISERS, LLC, and LOOMIS SAYLES & CO L P.
This page lists
135
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
122
Q2 2023 holders
135
Holder diff
13
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.